Semaglutide (Ozempic, Wegovy, Rybelsus) is the most prescribed GLP-1 receptor agonist worldwide, with proven efficacy across diabetes, obesity, and cardiovascular outcomes
Increasing evidence suggests that abnormal crotonylation modifications are significantly connected to the onset and progression of various cancers
Injectable Semaglutide is more potent as it reduces the sugar levels in the blood of type 2 diabetes patients
- Benefits include enhanced muscle growth, improved injury repair and healing, reduces the feeling of hunger, which can be beneficial for individuals looking to lose weight, anti-aging properties, improved libido, better sleep quality, and overall well-being